EFFECT OF MACITENTAN ON PULMONARY ARTERIAL HYPERTENSION-RELATED HOSPITALISATIONS: RESULTS FROM THE RANDOMISED CONTROLLED SERAPHIN TRIAL

被引：0
|
作者：
Coghlan, G. [1 ]
Channick, R. N. [2 ]
Rubin, L. J. [3 ]
Galie, N. [4 ]
Perchenet, L. [5 ]
Simonneau, G. [6 ]
机构：
[1] Royal Free Hosp, London NW3 2QG, England
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Univ Calif San Diego, San Diego, CA 92103 USA
[4] Univ Bologna, Bologna, Italy
[5] Actel Pharmaceut Ltd, Allschwil, Switzerland
[6] Hop Univ Bicetre, Le Kremlin Bicetre, France
来源：
THORAX | 2013年 / 68卷
关键词：
D O I：
10.1136/thoraxjnl-2013-204457.299
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：A143 / A143
页数：1
相关论文
共 50 条
  • [41] THE EFFECT OF TREPROSTINIL DOSE ON TIME TO ALL CAUSE AND PULMONARY ARTERIAL HYPERTENSION-RELATED HOSPITALIZATIONS
    Broderick, Meredith
    Ramani, Gautam
    Borg, Erick
    Saunders, Amanda
    Nelsen, Andrew
    [J]. CHEST, 2018, 154 (04) : 94A - 95A
  • [42] Initial combination therapy with ambrisentan plus tadalafil on pulmonary arterial hypertension-related hospitalization in the AMBITION trial
    Vachiery, Jean-Luc
    Galie, Nazzareno
    Barbera, Joan Albert
    Frost, Adaani E.
    Ghofrani, Hossein-Ardeschir
    Hoeper, Marius M.
    McLaughlin, Vallerie V.
    Peacock, Andrew J.
    Simonneau, Gerald
    Blair, Christiana
    Miller, Karen L.
    Langley, Jonathan
    Rubin, Lewis J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (02): : 194 - 202
  • [43] Prognostic Indicators Of Long-Term Outcome In Pulmonary Arterial Hypertension: Results From The Seraphin Event-Driven Morbidity/mortality Trial
    Delcroix, M.
    Channick, R. N.
    Galie, N.
    Ghofrani, H. A.
    Jansa, P.
    Mehta, S.
    Perchenet, L.
    Pulido, T.
    Sastry, B.
    Sitbon, O.
    Souza, R.
    Torbicki, A.
    Verweij, P.
    Rubin, L. J.
    Simonneau, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [44] INITIAL TREATMENT COMBINATION WITH MACITENTAN AND TADALAFIL IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE OPTIMA STUDY
    Sitbon, Olivier
    Canuet, Matthieu
    Picard, Francois
    Gregoire, Prevot
    Bergot, Emmanuel
    Cottin, Vincent
    Bauer, Fabrice
    Degano, Bruno
    Gressin, Virginie
    Perchenet, Loic
    Clerson, Pierre
    Simonneau, Gerald
    [J]. CHEST, 2019, 156 (04) : 870A - 871A
  • [45] Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension - results from a large European multicentre randomised controlled trial
    Grunig, Ekkehard
    MacKenzie, Alison
    Peacock, Andrew J.
    Eichstaedt, Christina
    Benjamin, Nicola
    Nechwatal, Robert
    Ulrich, Silvia
    Saxer, Stephanie
    Bussotti, Maurizio
    Sommaruga, Marinella
    Ghio, Stefano
    Gumbiene, Lina
    Paleviciute, Egle
    Jureviciene, Elena
    Cittadini, Antonio
    Stanziola, Anna A.
    Marra, Alberto M.
    Kovacs, Gabor
    Olschewski, Horst
    Barbera, Joan-Albert
    Blanco, Isabel
    Spruit, Martijn A.
    Franssen, Frits M. E.
    Noordegraaf, Anton Vonk
    Reis, Abilio
    Santos, Mario
    Viamonte, Sofia Goncalves
    Demeyer, Heleen
    Delcroix, Marion
    Bossone, Eduardo
    Johnson, Martin
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [46] Pulmonary arterial hypertension-related myopathy: An overview of current data and future perspectives
    Marra, A. M.
    Arcopinto, M.
    Bossone, E.
    Ehlken, N.
    Cittadini, A.
    Gruenig, E.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2015, 25 (02) : 131 - 139
  • [47] Transition from epoprostenol to treprostinil in pulmonary arterial hypertension: a controlled trial
    Schilz, R.
    Rubenfire, M.
    Mclaughlin, V.
    Allen, R.
    Elliott, G.
    Park, M.
    Wade, M.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 622 - 622
  • [48] Transition from epoprostenol to treprostinil in pulmonary arterial hypertension: A controlled trial
    Rubenfire, Melvyn
    McLaughlin, Vallerie
    Allen, Roblee
    Elliott, Gregory
    Park, Myung
    Wade, Michael
    Schilz, Robert J.
    [J]. CHEST, 2006, 130 (04) : 258S - 258S
  • [49] Macitentan Improves Health- Related Quality of Life for Patients With Pulmonary Arterial Hypertension
    Mehta, Sanjay
    Sastry, Bhagavatula Kutumba Srinivasa
    Souza, Rogerio
    Torbicki, Adam
    Ghofrani, Hossein-Ardeschir
    Channick, Richard N.
    Delcroix, Marion
    Pulido, Tomas
    Simonneau, Gerald
    Wlodarczyk, John
    Rubin, Lewis J.
    Jansa, Pavel
    Hunsche, Elke
    Galie, Nazzareno
    Perchenet, Loic
    Sitbon, Olivier
    [J]. CHEST, 2017, 151 (01) : 106 - 118
  • [50] ADJUSTING OVERALL SURVIVAL ESTIMATES AFTER TREATMENT SWITCHING IN PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE SERAPHIN RANDOMIZED STUDY
    Di Scala, L.
    Bacchi, M.
    Bayer, B.
    Turricchia, S.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S325 - S325
12345